Trillium Meds Review 2026: Pricing Model, Pharmacies & How It Compares

What is Trillium Meds?

Trillium Meds is a subscription-based telehealth access service headquartered in Portland, Oregon, connecting adults to licensed healthcare providers and regulated pharmacies for GLP-1–based weight management in all 50 states and Puerto Rico. Its homepage reports more than 10,000 patients served, displays LegitScript certification, advertises no membership fees, and accepts Klarna and Affirm financing (all verified on trytrillium.com, August 2026).

Two things make Trillium different from most GLP-1 telehealth brands. First, it is small: third-party reviews consistently describe it as an owner-operated business with an unusually direct line to the person running it, including an active presence in Reddit's GLP-1 communities. Second, and more importantly, it is structured as a marketplace, not a program. Where most platforms quote one price and route your prescription to a pharmacy you never see named, Trillium's comparison tool shows you competing offers from specific pharmacies — with the formulation, plan total, beyond-use date, and shipping carrier printed on each card before you commit.

Trillium is explicit that it is a non-clinical platform. Per its terms of service, it does not provide medical care or make clinical decisions; telehealth services are provided through independent provider networks — Beluga Health and Wasef Health are named as providers of record — and prescriptions, if issued, are filled by state-licensed or FDA-registered pharmacies. That structure is common in telehealth, and Trillium documents it more plainly than most. Its own compounding disclosure is similarly direct:

“Compounded medications … are not FDA-approved [and] are not evaluated by the FDA for safety or effectiveness.”

How the Trillium program works

The patient flow has four steps, per Trillium's own description: you complete a secure health intake; an independent licensed provider reviews it and decides whether treatment may be appropriate; if so, the provider may issue a prescription; and the prescription is then sent to a licensed pharmacy, which prepares and ships the medication. Trillium's role is administrative — the clinical decision belongs entirely to the provider.

The distinctive part happens before intake. On the weight-management page, you pick your medication — compounded tirzepatide (a GLP-1/GIP dual agonist) or compounded semaglutide (a GLP-1 receptor agonist) — and then compare offers from named pharmacies. As of August 2026 the tool listed five: Hyalo Technologies, Nova Specialty, Hallandale, VialsRx, and Drug Crafters, each with its own formulation notes (non-additive, or compounded with glycine, vitamin B6, or vitamin B12). Every offer card shows exact self-pay plan totals, where the pharmacy ships, and the product's beyond-use date.

That level of pharmacy transparency is genuinely rare in this market, and it is worth crediting. It is the same information we tell readers to demand from any provider in our compounded semaglutide cost guide: which licensed pharmacy prepares your prescription, what the all-in total is, and what happens as your dose changes. Trillium answers those questions on the offer card instead of making you email support.

Trillium Meds pricing: what we could verify in August 2026

Trillium's homepage advertises weight-management plans “as low as $86/month.” Because pricing lives inside a per-pharmacy comparison tool, the exact number you see depends on the medication, pharmacy, and plan you select. Here is the tirzepatide offer we verified directly on the site in August 2026, from the Hyalo Technologies Pharmacy listing:

• 1-month plan: $199 total — one vial, any dose
• 3-month starter plan: $399 total — three vials, titrated starter doses, available only to patients new to GLP-1s
• 3-month plan: $499 total — three vials, any dose (about $166/month)

The listing also showed a beyond-use date of up to 270 days, FedEx shipping, and delivery to all US states. Semaglutide offers appear in the same tool with their own per-pharmacy totals; we could not capture those figures in a static check, so treat the $86/month homepage figure as Trillium's advertised floor and verify current rates directly before enrolling. If you are weighing a 3-month structure like Trillium's, our guide to 3-month GLP-1 supplies explains how multi-vial shipments and beyond-use dates work.

Two fine-print notes. Trillium advertises no membership fees, and the offers we saw were presented as all-in totals — but its terms of service reserve the right to charge “platform access fees” for non-clinical administrative services, so read your final checkout total. And as with any “starting at” price in this market, the lowest advertised number applies to a specific plan and pharmacy, not to every combination in the tool.

Trillium Meds vs Trimi: marketplace vs flat price

These two platforms answer the same question — how do I get supervised compounded GLP-1 treatment at a fair cash price? — with opposite structures. All Trillium facts below were verified against its public site in August 2026; verify current rates with each provider.

On tirzepatide, the math is straightforward to compare at the plans we verified: Trillium's three-month any-dose plan totals $499, about $166/month, and its one-month plan is $199. Trimi's annual plan is $125/month at every prescribed dose — the full breakdown is in our compounded tirzepatide cost guide. On semaglutide, Trillium's lowest advertised weight-management price ($86/month) sits below Trimi's $99/month — though which specific offers carry that floor appears only inside its comparison tool — which is exactly the trade Trillium's model is built around: shorter commitments and pharmacy choice, at plan-dependent prices.

What Trillium does well — and the trade-offs

A fair review credits what this platform gets right:

And the trade-offs to weigh:

Who each platform fits

If you are already on treatment elsewhere and weighing a move in either direction, our guide to switching GLP-1 providers covers how to change platforms without interrupting your titration schedule. And if you are comparing several providers at once, our Mochi Health review walks through a membership-fee model that contrasts with both platforms here.

What to realistically expect from treatment

Whichever platform you choose, the medication does the heavy lifting, and the published evidence comes from trials of the FDA-approved products, not of compounded preparations. According to the STEP 1 trial published in the New England Journal of Medicine (2021), semaglutide 2.4 mg produced a 14.9% average body-weight reduction over 68 weeks alongside diet and exercise changes. For tirzepatide, the SURMOUNT-1 trial (New England Journal of Medicine, 2022) reported 20.9% average body-weight reduction at the highest dose over 72 weeks. Compounded preparations have not been studied in trials of their own, and individual results vary.

Per FDA guidance on compounding, compounded drugs are not reviewed by the agency for safety, effectiveness, or quality before marketing, and should be prepared by a state-licensed pharmacy against an individual prescription. Both Trillium and Trimi operate on that model — Trillium through the pharmacies named in its comparison tool, Trimi through VialsRx (Texas State Board of Pharmacy #35264) and GreenwichRx. Whoever you choose, confirm the pharmacy's state license and your provider's credentials before starting.

Frequently asked questions

Verdict: a credible marketplace — if you want to do the comparing

Trillium Meds is a legitimate, transparency-forward smaller player. Naming every pharmacy, printing exact plan totals, and publishing plain-language disclosures are practices we would like to see the whole market adopt. Its marketplace model rewards patients who enjoy doing their own diligence and want short commitments while they decide.

The flip side is that the marketplace hands you the work and the price variance. Your monthly cost depends on the pharmacy, plan length, and medication you pick, and the shortest plans carry the highest monthly rates. Patients who already know they want a sustained, supervised course of compounded GLP-1 treatment — and want one predictable number for it — are the patients flat-price programs were built for. That is the lane Trimi occupies at $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan, founded May 2024 and headquartered in New York City.